NO20002789L - Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav - Google Patents

Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav

Info

Publication number
NO20002789L
NO20002789L NO20002789A NO20002789A NO20002789L NO 20002789 L NO20002789 L NO 20002789L NO 20002789 A NO20002789 A NO 20002789A NO 20002789 A NO20002789 A NO 20002789A NO 20002789 L NO20002789 L NO 20002789L
Authority
NO
Norway
Prior art keywords
protein
methods
preparation
hydrophobically modified
modified protein
Prior art date
Application number
NO20002789A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002789D0 (no
Inventor
R Blake Pepinsky
Darren P Baker
Dingyi Wen
Kevin P Williams
Ellen A Garber
Frederick R Taylor
Alphonse Galdes
Jeffrey Porter
Original Assignee
Curis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curis Inc filed Critical Curis Inc
Publication of NO20002789D0 publication Critical patent/NO20002789D0/no
Publication of NO20002789L publication Critical patent/NO20002789L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Graft Or Block Polymers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20002789A 1997-12-03 2000-05-31 Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav NO20002789L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6742397P 1997-12-03 1997-12-03
US7893598P 1998-03-20 1998-03-20
US8968598P 1998-06-17 1998-06-17
US9980098P 1998-09-10 1998-09-10
PCT/US1998/025676 WO1999028343A2 (en) 1997-12-03 1998-12-03 Hydrophobically-modified protein compositions and methods

Publications (2)

Publication Number Publication Date
NO20002789D0 NO20002789D0 (no) 2000-05-31
NO20002789L true NO20002789L (no) 2000-08-02

Family

ID=27490628

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002789A NO20002789L (no) 1997-12-03 2000-05-31 Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav

Country Status (25)

Country Link
US (1) US6444793B1 (cs)
EP (1) EP1036092B1 (cs)
JP (1) JP4289788B2 (cs)
KR (1) KR20010032753A (cs)
CN (1) CN1294595A (cs)
AT (1) ATE295372T1 (cs)
AU (1) AU757497B2 (cs)
BR (1) BR9815142A (cs)
CA (1) CA2309806A1 (cs)
CZ (1) CZ20002008A3 (cs)
DE (1) DE69830192T2 (cs)
DK (1) DK1036092T3 (cs)
EA (1) EA003739B1 (cs)
EE (1) EE200000308A (cs)
ES (1) ES2243018T3 (cs)
HU (1) HUP0100535A3 (cs)
IL (2) IL136137A0 (cs)
IS (1) IS2163B (cs)
MX (1) MXPA00005494A (cs)
NO (1) NO20002789L (cs)
NZ (1) NZ504752A (cs)
PL (1) PL197833B1 (cs)
PT (1) PT1036092E (cs)
TR (1) TR200001612T2 (cs)
WO (1) WO1999028343A2 (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2312009A1 (en) * 1997-11-28 1999-06-10 Roche Diagnostics Gmbh An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
CA2309806A1 (en) 1997-12-03 1999-06-10 Biogen, Inc. Hydrophobically-modified protein compositions and methods
US6897297B1 (en) 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
EP1557427A3 (en) * 1998-04-30 2005-10-19 Curis, Inc. Hedgehog protein conjugate
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
EP1133519B1 (en) * 1998-11-02 2008-08-13 Curis, Inc. Functional antagonists of hedgehog activity
CA2352570A1 (en) * 1998-12-03 2000-06-22 Biogen, Inc. Methods and compositions for treating disorders involving excitotoxicity
EP1025861A1 (de) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Pharmazeutische Zusammensetzung von hydrophob modifizierten Hedgehog-Proteinen und deren Verwendung
AU782493B2 (en) * 1999-06-01 2005-08-04 Curis, Inc. Polymer conjugates of hedgehog proteins and uses
AU2005203058C1 (en) * 1999-11-05 2009-07-02 Curis, Inc. Hedgehog fusion proteins and uses
IL149202A0 (en) 1999-11-05 2002-11-10 Biogen Inc Hedgehog fusion proteins and uses
AU2001255767A1 (en) * 2000-04-28 2001-11-12 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
EP1504111A4 (en) * 2002-04-19 2005-11-23 California Inst Of Techn LIBRARY OF MOLECULES OF NUCLEIC ACIDS AND PEPTIDES IN WHICH THE PEPTIDES CONTAIN NON-NATURAL AMINO ACID RESIDUES AND METHODS FOR THEIR PRODUCTION
WO2006019904A1 (en) 2004-07-14 2006-02-23 University Of Utha Research Foundation Netrin-related compositions and uses
EP1862180A4 (en) * 2005-03-25 2010-09-15 Takeda Pharmaceutical MEDICINE FOR PROPHYLAXIS / TREATMENT OF CANCER
CA2629346A1 (en) * 2005-11-11 2007-05-18 Proteogen Bio S.R.L. Method of converting water-soluble active proteins into hydrophobic active proteins, the use of the same for the preparation of monomolecular layers of oriented active proteins, and devices comprising the same
WO2008057468A1 (en) 2006-11-02 2008-05-15 Curis, Inc. Small organic molecule regulators of cell proliferation
KR100876657B1 (ko) * 2007-10-15 2009-01-07 한국기계연구원 표면개질된 마이크로비드와 마이크로비드 어레이칩의제조방법과 마이크로비드 어레이칩을 이용한 질병특이항원의 확인방법
JP5576801B2 (ja) * 2008-02-21 2014-08-20 ダーマケア・ニューロサイエンス・インスティテュート Ｍｎｔｆペプチドの美容および皮膚科用製剤
WO2009108868A2 (en) * 2008-02-27 2009-09-03 Radiomedix Inc. Radiolabeled hedgehog derivatives for imaging and therapy
UA107571C2 (xx) * 2009-04-03 2015-01-26 Фармацевтична композиція
CN103665095A (zh) * 2012-09-11 2014-03-26 中国人民解放军军事医学科学院卫生学环境医学研究所 一种疏水性多肽修饰抗体的合成方法
CN106924754B (zh) * 2015-12-30 2021-11-09 北京大学 聚氨基酸偶联物
CN108147990B (zh) * 2016-12-02 2023-01-24 上海中医药大学 一种膜锚定元件及其应用
EP3700556A2 (en) 2017-10-25 2020-09-02 Janssen Pharmaceuticals, Inc. Compositions of phosphorylated tau peptides and uses thereof
MY206596A (en) 2019-02-08 2024-12-25 Janssen Pharmaceuticals Inc Method of safe administration of phosphorylated tau peptide vaccine
JP2023136614A (ja) * 2022-03-17 2023-09-29 三菱ケミカル株式会社 植物を用いたヘッジホッグタンパク質の製造方法
CN116983461B (zh) * 2023-03-14 2025-07-22 中国石油大学(华东) 基于脂质体修饰的止血海绵体系
CN116549713B (zh) * 2023-05-09 2025-06-13 浙江大学 一种兼具组织粘合和防粘连的手术贴片和其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5409611A (en) * 1988-03-24 1995-04-25 Terrapin Technoogies, Inc. Method to identify analyte-binding ligands
US5130297A (en) 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
US5824315A (en) * 1993-10-25 1998-10-20 Anergen, Inc. Binding affinity of antigenic peptides for MHC molecules
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5869602A (en) * 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
EP0966478A4 (en) * 1996-10-07 2002-08-21 Univ Johns Hopkins Med Novel hedgehog-derived polypeptides
CA2309806A1 (en) 1997-12-03 1999-06-10 Biogen, Inc. Hydrophobically-modified protein compositions and methods

Also Published As

Publication number Publication date
CA2309806A1 (en) 1999-06-10
EA003739B1 (ru) 2003-08-28
CZ20002008A3 (cs) 2001-11-14
WO1999028343A2 (en) 1999-06-10
JP4289788B2 (ja) 2009-07-01
KR20010032753A (ko) 2001-04-25
WO1999028343A9 (en) 1999-10-14
DE69830192T2 (de) 2006-01-12
HUP0100535A2 (hu) 2001-06-28
HK1030953A1 (en) 2001-05-25
PL341430A1 (en) 2001-04-09
AU1996699A (en) 1999-06-16
BR9815142A (pt) 2000-10-10
EA200000605A1 (ru) 2000-12-25
IS5499A (is) 2000-05-15
DE69830192D1 (de) 2005-06-16
NO20002789D0 (no) 2000-05-31
ATE295372T1 (de) 2005-05-15
ES2243018T3 (es) 2005-11-16
IS2163B (is) 2006-11-15
AU757497B2 (en) 2003-02-20
CN1294595A (zh) 2001-05-09
MXPA00005494A (es) 2003-05-19
JP2001525336A (ja) 2001-12-11
TR200001612T2 (tr) 2001-01-22
IL136137A0 (en) 2001-05-20
EE200000308A (et) 2001-10-15
US6444793B1 (en) 2002-09-03
PT1036092E (pt) 2005-09-30
EP1036092B1 (en) 2005-05-11
HUP0100535A3 (en) 2003-09-29
IL136137A (en) 2009-09-22
DK1036092T3 (da) 2005-08-15
WO1999028343A3 (en) 1999-08-12
NZ504752A (en) 2002-10-25
PL197833B1 (pl) 2008-04-30
EP1036092A2 (en) 2000-09-20

Similar Documents

Publication Publication Date Title
NO20002789L (no) Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav
ATE330224T1 (de) Funktionelles protein array
EP1067182A3 (en) Secretory protein or membrane protein
KR870001237A (ko) 혈액응고 억제작용을 갖는 폴리펩티드의 분리 및 제조 방법
ATE431834T1 (de) Prozess zur trennung von proteinen
IL115199A (en) Composition comprising a polynucleic acid molecule in a liposome and method using said composition
WO2004058946A3 (en) Protein arrays
ATE500323T1 (de) Subtilisin-variante
DK162233C (da) Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
AR014891A1 (es) Genes aislados de proteinas de membranas de mamiferos; reactivos relacionados
WO1996038553A1 (en) A method for identification of biologically active peptides and nucleic acids
WO2000000600A3 (en) Lentiviral vectors, comprising modified major donor splice sites and major packaging signals
KR880701778A (ko) 펩티드의 합성 및 분리를 위한 효소막법
JP2004535152A (ja) 細胞培養物に対する成長影響活性を有するカゼインペプチドフラグメント
ATE46703T1 (de) Regionspezifische determinanten fuer vitamin-k abhaengiges knochenprotein.
NO984491D0 (no) SCF-analogpreparater og fremgangsmÕte for fremstilling av disse
BR9714133A (pt) ácido nucleico isolado, molécula do mesmo, sonda, vetor de expressão recombinante, célula, polipeptìdeo, proteìna de fusão formulação de vacina e processos para produzir um polipeptìdeo de h. pylori, para detctar a presença de um ácido nucleico de helicobacter em uma amostra, para tratar ou reduzir um risco de infecção por h. pylori em um indivìduo e para produzir uma formulação de vacina
Gahmberg et al. Cell surface proteins: changes during cell growth and malignant transformation
WO1999028876A3 (en) Hydrophobically-modified protein compositions and methods
Ogishima et al. Partial amino acid sequences of two mitochondrial and two microsomal cytochrome P-450's from adrenal cortex
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
CY1105486T1 (el) Τροποποιημενες υδροφοβικα συνθεσεις πρωτεϊνων ακανθοχοιρου και μεθοδοι παρασκευης αυτων
BR0213772A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina
WO2001025430A3 (en) Novel human membrane proteins
RU94046405A (ru) Птг-соединения и содержащий их фармацевтический состав, способ получения желаемых полипептидов, нуклеотидная последовательность, бактериальный вектор экспрессии, бактериальные хозяйские клетки и составной белок

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application